A PI3K inhibitor, LY294002 [29], dose-dependently suppressed the TGFα-induced AKT phosphorylation at both the serine and threonine residues in the HuH7 cells, suggesting that PI3K also regulates the AKT activity in HCC cells (Figure 2). The gene discussed is AKT1; the disease is hepatocellular carcinoma.